-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on AVITA Medical, Raises Price Target to $14

Benzinga·08/19/2026 15:10:54
Listen to the news
TD Cowen analyst Joshua Jennings maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $12 to $14.